Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Ann Neurol. 2010 Aug;68(2):220-30. doi: 10.1002/ana.22052.
Recent evidence suggests that high molecular weight soluble oligomeric Abeta (oAbeta) assemblies (also known as Abeta-derived diffusible ligands, or ADDLs) may represent a primary neurotoxic basis for cognitive failure in Alzheimer disease (AD). To date, most in vivo studies of oAbeta/ADDLs have involved injection of assemblies purified from the cerebrospinal fluid of human subjects with AD or from the conditioned media of Abeta-secreting cells into experimental animals. We sought to study the bioactivities of endogenously formed oAbeta/ADDLs generated in situ from the physiological processing of human amyloid precursor protein (APP) and presenitin1 (PS1) transgenes.
We produced and histologically characterized single transgenic mice overexpressing APP(E693Q) or APP(E693Q) X PS1DeltaE9 bigenic mice. APP(E693Q) mice were studied in the Morris water maze (MWM) task at 6 and 12 months of age. Following the second MWM evaluation, mice were sacrificed, and brains were assayed for Abetatotal, Abeta40, Abeta42, and oAbeta/ADDLs by enzyme-linked immunosorbent assay (ELISA) and were also histologically examined. Based on results from the oAbeta/ADDL ELISA, we assigned individual APP(E693Q) mice to either an undetectable oAbeta/ADDLs group or a readily detectable oAbeta/ADDLs group. A days to criterion (DTC) analysis was used to determine delays in acquisition of the MWM task.
Both single transgenic and bigenic mice developed intraneuronal accumulation of APP/Abeta, although only APP(E693Q) X PS1Delta9 bigenic mice developed amyloid plaques. The APP(E693Q) mice did not develop amyloid plaques at any age studied, up to 30 months. APP(E693Q) mice were tested for spatial learning and memory, and only 12-month-old APP(E693Q) mice with readily detectable oAbeta/ADDLs displayed a significant delay in acquisition of the MWM task when compared to nontransgenic littermates.
These data suggest that cerebral oAbeta/ADDL assemblies generated in brain in situ from human APP transgenes may be associated with cognitive impairment. We propose that a DTC analysis may be a sensitive method for assessing the cognitive impact in mice of endogenously generated oligomeric human Abeta assemblies. ANN NEUROL 2010.
最近的证据表明,高分子量可溶性寡聚态 Aβ(oAbeta)聚合体(也称为 Aβ衍生的可扩散配体,或 ADDLs)可能代表阿尔茨海默病(AD)认知失败的主要神经毒性基础。迄今为止,大多数关于 oAbeta/ADDL 的体内研究都涉及将从 AD 患者的脑脊液中纯化的或从 Aβ分泌细胞的条件培养基中提取的 oAbeta/ADDL 聚合体注射到实验动物体内。我们试图研究源自人淀粉样前体蛋白(APP)和早老素 1(PS1)转基因生理加工的内源性形成的 oAbeta/ADDL 的生物活性。
我们生成并组织学特征分析了过表达 APP(E693Q)或 APP(E693Q)XPS1DeltaE9 双转基因小鼠的单转基因小鼠。在 6 个月和 12 个月大时,APP(E693Q)小鼠在 Morris 水迷宫(MWM)任务中进行研究。在第二次 MWM 评估后,处死小鼠,通过酶联免疫吸附试验(ELISA)检测大脑中的 Aβ总量、Aβ40、Aβ42 和 oAbeta/ADDLs,并进行组织学检查。根据 oAbeta/ADDL ELISA 的结果,我们将个别 APP(E693Q)小鼠分配到 oAbeta/ADDLs 无法检测到的组或 oAbeta/ADDLs 可轻易检测到的组。采用到达标准天数(DTC)分析来确定 MWM 任务获取的延迟。
单转基因和双转基因小鼠均出现了 APP/Abeta 的神经元内蓄积,尽管只有 APP(E693Q)XPS1Delta9 双转基因小鼠出现了淀粉样斑块。在任何研究的年龄,APP(E693Q)小鼠均未出现淀粉样斑块,最高可达 30 个月。APP(E693Q)小鼠接受空间学习和记忆测试,只有可检测到 oAbeta/ADDLs 的 12 月龄 APP(E693Q)小鼠在 MWM 任务获取方面出现显著延迟,与非转基因同窝仔相比。
这些数据表明,源自人 APP 转基因的脑内原位形成的脑 oAbeta/ADDL 聚合体可能与认知障碍有关。我们提出,DTC 分析可能是评估内源性生成的寡聚人 Aβ 聚合体对小鼠认知影响的敏感方法。